| Literature DB >> 33234023 |
Jordan H Driskill1,2, Duojia Pan1.
Abstract
Studies of the regenerative capacity of the liver have converged on the Hippo pathway, a serine/threonine kinase cascade discovered in Drosophila and conserved from unicellular organisms to mammals. Genetic studies of mouse and rat livers have revealed that the Hippo pathway is a key regulator of liver size, regeneration, development, metabolism, and homeostasis and that perturbations in the Hippo pathway can lead to the development of common liver diseases, such as fatty liver disease and liver cancer. In turn, pharmacological targeting of the Hippo pathway may be utilized to boost regeneration and to prevent the development and progression of liver diseases. We review current insights provided by the Hippo pathway into liver pathophysiology. Furthermore, we present a path forward for future studies to understand how newly identified components of the Hippo pathway may control liver physiology and how the Hippo pathway is regulated in the liver.Entities:
Keywords: Hippo pathway; YAP/TAZ; fatty liver disease; liver cancer; metabolism; regeneration
Mesh:
Substances:
Year: 2020 PMID: 33234023 DOI: 10.1146/annurev-pathol-030420-105050
Source DB: PubMed Journal: Annu Rev Pathol ISSN: 1553-4006 Impact factor: 23.472